Dr. Eva Feldman to headline fall Health Science Lecture
Dr. Eva Feldman will headline the fall Health Science Lecture on Wednesday, Oct. 2, with an update on her landmark trial of a stem cell therapy for ALS. The trial, in which patients receive the surgical implantation of stem cells directly to their spinal cords, is expected to move into Phase 2 this fall in Ann Arbor.
The lecture takes place from 6-7 p.m. in the Kahn Auditorium of the A. Alfred Taubman Biomedical Science Research Building on the University of Michigan campus. It is open to the general public; no registration is required. Click here for directions.
The Health Science Lecture Series is sponsored by the Taubman Institute, the Program for Biology and a number of student organizations. The lectures will be held quarterly on the U-M campus and will focus on a wide variety of topics including medical research, public health, bioethics, evolutionary biology, epidemiology and many others.
Visiting Professor lecture to feature genetics expert
Brendan Lee, M.D., Ph.D., a genetics expert from Baylor College of Medicine, will headline the Pediatrics Research Symposium Oct. 6 at the U-M Medical School.
Click here for details and registration information.
New U-M President visits Taubman Institute
The Institute hosted a fellow clinician-scientist when the University of Michigan’s new president paid a visit to the A. Alfred Taubman Biomedical Science Research Building.
People who care
Institute welcomes new gift officer
Maria Muller has been appointed to work with connect donors with funding opportunities at the Taubman Institute.
Click here to read more.
news & events
Institute symposium set for Oct. 10
The A. Alfred Taubman Medical Research Institute will award the 2014 $100,000 Taubman Prize for Excellence in Translational Medical Science at its 7th annual symposium at 10 a.m. on Oct. 10.
Dr. Carl June, a physician-scientist who developed a personalized immunotherapy for leukemia using patients’ own T cells, will receive the honor and deliver the symposium's keynote address.
Click here for symposium details.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.